⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 10, 2024VaccinesOpen Access

Immune Response to an Inactivated Vaccine of SARS-CoV-2 (CoronaVac) in an Indigenous Brazilian Population: A Cohort Study

Laís Albuquerque de Oliveira Isa Rita Brito de Morais Marcelo dos Santos Barbosa Silvana Beutinger Marchioro Layla Oliveira Campos Leite Machado Michele Ferreira Marques Tiago da Silva Ferreira Gabriel Barroso de Almeida Dyjaene de Oliveira Barbosa Alex Torres Simone Simionatto

View Full Paper

Ask AI

Bookmark

Share

Abstract

Although the adaptive immune responses to the CoronaVac vaccine are known, their dynamics in indigenous communities remain unclear. In this study, we assessed the humoral and cellular immune responses to CoronaVac (Sinovac Biotech Life Sciences, 2021 NCT05225285, Beijing, China), in immunized Brazilian indigenous individuals.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oliveira et al. (2024) studied this question.

synapsesocial.com/papers/68e6fa8ab6db643587674ce6 https://doi.org/10.3390/vaccines12040402

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up2024 · 1 citations
2Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance studyCross-Sectional Study · 2026
3Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial2024 · 1 citations
4Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 CohortCohort Study · 2023 · 6 citations
5The Long-Term Serological Profile of CoronaVac Vaccine Based on Comorbidities and History of SARS-CoV-2 Infection in IndonesiaOriginal Research · 2023 · 1 citations

Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study2023
Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study2023
Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines2024
Immunity Gaps and Delayed Vaccination Assessment in Children After Hematopoietic Stem Cell Transplantation: A Single-Center Real-World AssessmentVaccines · 2026
Comparative Preclinical Evaluation of Three Recombinant Brucella Vaccine Formulations, BruVac-Pro, BruVac-CPX and BruVac-FLU, in a Murine Brucella melitensis Challenge ModelVaccines · 2026

More from Vaccines

More from Universidade Federal da Bahia

More from Universidade Federal da Grande Dourados